Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

69 results about "Penicillin G Acylase" patented technology

Penicillin G acylase (PDB ID: 1AJQ) is found in the organism Escherichia coli. Penicillin G acylase has a molecular weight of 94,642.59 Da, and its isoelectric point (pI) is 6.17. It is part of the larger family of penicillin acylases that come from such microorganisms as bacteria, yeast, and fungi.

Mutation penicillin G acylase, recombinant expression plasmid and transformation engineering strains thereof

ActiveCN101177688AImprove synthesis abilityMaximum conversion rate increaseBacteriaHydrolasesHydrolysatePolymerase L
The invention relates to a gene, mutant plasmid and engineering bacteria which have improved synthesis performance to penicillin G acylase and are obtained by a gene site-directed mutagenesis method, and mutant enzyme can also be obtained with improved synthesis performance to penicillin G acylase by fermenting and purifying the engineering bacteria. Two enzymes Kpn I and Pst I are firstly used for cutting pUC18 by the invention, then T4 polymerase is adopted to make the ends blunt, and pZ01 is obtained through self-linkage; the enzyme of EcoR I is used for cutting pZ01, and then connected with pEES102 that is also cut by the enzyme of EcoR I, thereby obtaining the recombinant plasmid pY020; the pY020 is adopted as a template plasmid, and TaKaRa MuTanBEST Kit is utilized for conducting the site-directed mutagenesis to B.megaterium PGA, thereby obtaining the mutant plasmid with improved synthesis performance to the penicillin G acylase. The mutant plasmid is transformed to bacillus subtilis to obtain the required engineering bacteria. The engineering bacteria are amplified and fermented, and the mutant enzyme with improved maximum conversion rate of 7-ADCA and the ratio of synthetic product / hydrolysate can be obtained after the engineering bacteria are purified.
Owner:SHANXI WEIQIDA PHARMA IND

Improved method for preparing amoxicillin by enzymic method

The invention relates to the field of pharmacy, and provides an improved method for preparing amoxicillin by an enzymic method, and a product obtained by the improved method for preparing amoxicillin by the enzymic method. The method comprises the following steps of: 1) dissolving 6-aminopenicillanic acid (6-APA) at the temperature of between 10 and 20 DEG C by using water or/and aqueous solution of ammonia which has the pH value of 7.0 to 8.0, and adding D-p-Hydroxyphenylglycine methyl ester hydrochlorid and penicillin G acyltransferase; 2) adjusting the pH value of a solution obtained in the step 1) to be 6.0 to 6.5, and reacting at the temperature of between 21 and 30 DEG C until the content of 6-APA is less than 5mg/ml to obtain a solution of an amoxicillin product; and 3) separating the penicillin G acyltransferase from the solution of the amoxicillin product, adjusting by using hydrochloric acid until the solution of the amoxicillin product is clarified, adding the aqueous solution of ammonia, adjusting the pH value to be 5.5 to 6.5, and crystallizing at the temperature of between 0 and 5 DEG C to obtain amoxicillin. By the improved method for preparing amoxicillin by the enzymic method, the quality of the amoxicillin product is greatly improved, and the medication safety of the amoxicillin product is further improved.
Owner:UNITED LAB INNER MONGOLIA CO LTD

Mutant of penicillin G acylase (PGA) and preparation method and application of mutant

ActiveCN105087533AStrong concentration toleranceIncreased concentration toleranceHydrolasesFermentationPhenyl acetic acidEscherichia coli
The invention provides a mutant of penicillin G acylase (PGA) and a preparation method and application of the mutant. The non-rationally and semi-rationally designed enzyme engineering reconstruction technology is adopted for mutation of penicillin G acylase obtained from Escherichia coli ATCC 11105, so that a PGA mutant with higher reactivity, higher reaction rate, better conversion rate, stronger in penicillihe concentration tolerance, less substrate residue, and higher in phenyl acetic acid concentration tolerance; meanwhile, the mutant is subjected to recombinant expression, bacteria strain construction, fermenting cultivation, immobilization and application to prepare 6-amino-penicillanic acid (6-APA). The activity of the PGA-6 mutant prepared by the invention is increased by 102 times, the substrate penicillihe concentration tolerance is increased to 30%, and the phenyl acetic acid concentration tolerance is increased to 20 mmol/L; meanwhile, the immobilized PGA-6 mutant is used to decompose penicillihe with a concentration of 25% under the condition of pH 8.0 and 25 DEG C so as to prepare 6-APA, and the reaction time is shortened to 55 minutes, the substrate conversion rate is 98% or above, and after being used for 600 batches and above, the activity is not lost obviously, therefore, good operation stability is achieved.
Owner:HUNAN FLAG BIOTECHNOLOGY CO LTD

Process for direct preparation of amoxicillin by liquid 6-APA (amino penicillanic acid)

The invention belongs to the technical field of medicine preparation and relates to a process for direct preparation of amoxicillin by liquid 6-APA (amino penicillanic acid). The process includes: taking penicillin degreasing solution as an initial material, sequentially performing cracking reaction, extraction, phase splitting, resin column adsorptive purification, distillation and concentration to obtain a 6-APA solution with the concentration being 80-100g/L, and synthesizing with p-hydroxyphenylglycine methyl ester under a catalytic action of type-II penicillin G acylase to obtain the amoxicillin. Compared with a traditional method, the process has the advantages that subsequent steps of 6-APA crystallization, centrifuging, drying and the like are avoided, investment of fixed assets is reduced, energy loss, equipment loss and cost are reduced, profits are increased, and physical injuries of staffs are reduced. Compared with existing direct amoxicillin preparation methods, the process has the advantages that by adoption of dichloromethane as an extracting agent, total mole yield of amoxicillin is higher relatively, the extracting agent is easy for distillation separation, the content of residual solvents in products is greatly reduced, medication safety is improved, and the process is worthy of popularization in production.
Owner:INNER MONGOLIA CHANGSHENG PHARMA

Penicillin G acylase mutant for synthesis and application thereof in preparation of amoxicillin

ActiveCN105274082ASynthetic activity is goodImprove stabilityHydrolasesFermentationContinuous useOrthogenesis
The invention provides a penicillin G acylase mutant for synthesis and an application thereof in the preparation of amoxicillin. Penicillin G acylase of Achromobacter xylosoxidans origin is mutated by computer aided design in connection with semi-rational design of site-saturation mutagenesis technique and enzyme engineering modification of orthogenesis, thus acquiring the penicillin G acylase mutant lower in hydrolytic activity, better in synthetic activity, higher in synthesis-hydrolysis ratio (S / H), higher in acid resistance and better in stability, and amoxicillin can be catalytically synthesized more effectively and quickly. Immobilized enzyme hydrolytic activity of the mutant SPGA-4 obtained is decreased by 8.7 times, synthetic activity is increased by 5.6 times, the S / H ratio is increased by 8 times, the activity remains at 79% for 60 min under the condition of pH 2.0, amoxicillin is catalytically synthesized by a solid method at 10 DEG C or 20 DEG C, substrates 6-APA and D-HPM are directly charged in a solid form without dissolving, reaction pH need not be controlled, substrate conversion rate is higher than 99%, continuous use is available in more than 300 batches, and good operational stability is given.
Owner:HUNAN FLAG BIOTECHNOLOGY CO LTD

Penicillin G acylase containing one or a plurality of point mutation

The present invention relates to a new penicillin G acylase mutant, nucleic acid for encoding the mutant, a related expression vector, host cells, and a use of the mutant in amoxicillin synthesis.
Owner:CSPC ZHONGQI PHARM TECH (SHIJIAZHUANG) CO LTD

Penicillin G acylase mutant

The invention relates to a penicillin G acylase mutant constructed by genetic engineering. In comparison with wild type penicillin G acylase from achromobacter (Achromobacter sp.CCM 4824), the synthesis performance of the penicillin G acylase mutant is improved substantially, the maximum synthetic product / hydrolysate value S / H reaches 22.3 and is 3.9 times that of wild type enzyme, and various beta-lactam antibiotics can be efficiently synthesized catalytically. When the ratio of side chains to mother nucleus is 1.05:1, the conversion rate of the mother nucleus 6-APA, 7-ADCA, 7-ACCA and 7-APRA reaches 99.0% or above, and the penicillin G acylase mutant has wide industrial application prospects.
Owner:山西双雁生物科技有限公司

Method for enzymatic synthesis of cefprozil in recyclable aqueous two-phase system by using immobilized penicillin acylase

InactiveCN103451259AHigh yieldInhibit hydrolytic activityFermentationEnzymatic synthesisPenicillin
The invention discloses a method for the enzymatic synthesis of cefprozil in a recyclable aqueous two-phase system by using immobilized penicillin acylase. The method comprises the following steps: dissolving a cefprozil parent nucleus and an acylation reagent in an aqueous two-phase polymer solution, wherein the molar ratio of the parent nucleus to the acylation reagent is 1: (1-4); and adding immobilized penicillin G acylase, then adding a two-phase distribution conditioning agent, adjusting the pH value to 4.5-7, and reacting for 1 to 80 hours at the temperature of 5-30 DEG C, wherein the concentration of enzyme in a reaction system is 50-150U / ml. By adopting the method, the hydrolytic activity of the penicillin acylase can be effectively inhibited, thus the hydrolysis degrees of the acylation reagent and the cefprozil product can be reduced. Compared with a method using water as a medium, the method disclosed by the invention has the advantages that the product and the enzyme are distributed in two different water phases, a reactant is fully in contact with the enzyme, so that a synthesis / hydrolysis specific value is greatly increased, the yield of the cefprozil can be increased by 20%, and the highest yield can reach 78%; the adopted novel recyclable aqueous two-phase system can be recycled, so that the production cost is reduced.
Owner:南通康鑫药业有限公司 +1

Technology for preparing ampicillin by adopting enzymic method

ActiveCN103805672AOvercoming conversion rateOvercome purityFermentationAmpicillinSolvent
The invention discloses a technology for preparing ampicillin by adopting an enzymic method. The technology comprises the following steps of (a) mixing 6-aminopenicillanic acid, a phenylglycine derivative and penicillin G acylase into water to obtain mixed liquid; (b) adjusting and controlling the pH value of the mixed liquid to be 5.5-6.1 through acid or alkaline, and reacting under the temperature of 0-40 DEG C; (c) after the reaction is finished, performing separation, cleaning reaction liquid containing a coarse ampicillin product through the acid, crystallizing the reaction liquid through the alkaline, and performing grain cultivation, washing and drying to obtain an ampicillin product. The preparation technology provided by the invention is simple, convenient to operate, low in energy consumption, high in safety and high in stability; furthermore, the pH value required by a reaction system is easy to control, the reaction time is short, the conversion rate is up to over 99 percent, the product purity is high, and a solvent does not need to be recycled; and therefore, the low-cost and high-efficiency production technology can be popularized and applied in the industrial production.
Owner:NORTH CHINA PHARM GRP SEMISYNTECH CO LTD

Mutant penicillin g acylases

The present invention relates to a mutant prokaryotic penicillin G acylase derived from a wild-type penicillin G acylase characterized in that the mutant is having an amino acid substitution at one or more amino acid positions selected from the group consisting of amino acid positions A3, A77, A90, A144 A192, B24, B109, B148, B313, B460 and B488 according to the amino acid numbering of the Escherichia coli penicillin G acylase having the amino acid sequence depicted in SEQ ID No: 1.
Owner:DSM SINOCHEM PHARMA NETHERLANDS

Method for preparing (S)-2-chlorophenylglycine methyl ester single enantiomer by virtue of biological enzyme catalysis

The invention discloses a method for preparing an (S)-2-chlorophenylglycine methyl ester single enantiomer by virtue of biological enzyme catalysis. The method comprises the following steps: adding racemized 2-chlorophenylglycine methyl ester and a sodium phosphate buffer solution into a reactor with the water bath constant temperature of 30 DEG C, stirring, then adding penicillin G acylase, controlling the stirring rotating speed to be 100-500r/min, controlling the reaction time to be 20-60 hours, continuously stirring until reaction ends, and finally recycling penicillin G acylase. The method disclosed by the invention has the beneficial effects that PGA is adopted as a catalyst, and reaction under normal temperature and normal pressure by using the activity, high selectivity and specificity to substrates of PGA to prepare (S)-2-chlorophenylglycine methyl ester through one-step, so that protection and deprotection processes of reactive groups in chlorophenylglycine can be saved, the (S)-2-chlorophenylglycine methyl ester single enantiomer with higher optical purity also can be obtained, and the enantiomer excess can reach more than 95%; and the method is simple and easily-controllable in operation process, is low in energy consumption in a preparation process, is low in emission, and is of an environment-friendly preparation method.
Owner:NINGXIA UNIVERSITY

Preparation of magnetic immobilized penicillin G acylase doped with divalent manganese ions

The invention relates to preparation of magnetic immobilized penicillin G acylase doped with divalent manganese ions. The method comprises the following steps: (1) preparing magnetic nanoparticles ferroferric oxide@beta-cyclodextrin doped with divalent manganese ions; (2) carrying out mixed reaction on an ethanol solution of 3-glycidyl ether oxypropyl trimethoxy silane with the magnetic nanoparticle ferroferric oxide@beta-cyclodextrin doped with the divalent manganese ionst, so as to obtain a magnetic nanoparticle ferroferric oxide@beta-cyclodextrin-g-3-glycidyl ether oxypropyl trimethoxy silane carrier doped with the divalent manganese ions; and (3) adding the divalent manganese ion-doped magnetic nanoparticle ferroferric oxide@beta-cyclodextrin-g-3-glycidyl ether oxypropyl trimethoxy silane carrier dissolved in a phosphate buffer solution into a free penicillin G acylase solution, carrying out oscillatory reaction, and then carrying out vacuum drying to obtain the magnetic immobilized penicillin G acylase carrier doped with the divalent manganese ions. The method can effectively improve the enzyme activity recovery rate.
Owner:LANZHOU UNIVERSITY OF TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products